Öcal Duygu, Tekeli Alper, Dolapçı İştar
Ankara University Faculty of Medicine, Department of Medical Microbiology, Ankara, Türkiye.
Mikrobiyol Bul. 2022 Jul;56(3):506-524. doi: 10.5578/mb.20229710.
In view of the significant negative impact of biofilm-mediated infection on patient health and the necessity of a reliable phenotypic method to detect biofilm producers, this study aimed to demonstrate phenotypic and molecular biofilm formation in coagulase-negative staphylococci (CoNS) isolated from catheter related infections and to compare the methods used with each other. The study was also aimed to determine the biofilm eradication effect of vancomycin in order to guide for the treatment. For the detection of biofilm formation, a total of 154 CoNS clinical isolates of which 30 being causative agents of catheter related bloodstream infection (CRBSI) (isolated from both the catheter tip and blood cultures of 15 patients), 89 being isolated from peripheral blood cultures of patients without a central venous catheter (CVC) (13 of them were bloodstream infection agents, 76 of them were contaminant), and 35 being isolated as catheter colonizer, were screened by tissue culture plate (TCP), Congo red agar (CRA) method and polymerase chain reaction (icaA, icaD and IS256). Vancomycin minimum inhibitory concentration (MIC) and minimum biofilm eradicating concentration (MBEC) values were determined. The pulsed field gel electrophoresis (PFGE) method was used to show the clonal relationship between CoNS isolated from the catheter tips and peripheral blood of patients with CRBSI. Of the 154 CoNS isolates included in the study, 38.9% were Staphylococcus epidermidis (n= 60), 34.4% were Staphylococcus haemolyticus (n= 53), 20.7% were Staphylococcus hominis (n= 32), and 3.8% were detected as Staphylococcus capitis (n= 6). In our study, biofilm formation was shown in 31.8% with the CRA method and in 68.1% with the TCP method. By TCP method, 22% (n= 34) were determined as weak, 31.2% (n= 48) medium and 14.9% (n= 23) strong biofilm producers. While the sensitivity of the CRA method was found to be low for isolates that were determined as weak positive in the microplate method, the high sensitivity of the CRA method for isolates with medium and strong positivity was found remarkable. The positivity rates of icaA, icaD and IS256 genes in a total of 154 CoNS isolates were found to be 40 (25.9%), 57 (37%) and 77 (50%), respectively. In total, at least one gene positivity was detected in 107 (69.5%) isolates. Single gene positivity was detected in 55 (35.7%), two gene positivity in 35 (22.7%) and three gene positivity was detected in 17 (11%) of the included CoNS. Biofilm formation (four weak, four medium, two strong) was detected by microplate method in 10 of 47 CoNS isolates (five S.epidermidis, three S.hominis, one S.haemolyticus and one S.capitis) in which no genes were detected. Vancomycin MBEC/ MIC values were found to be high and it was observed that as the biofilm forming power of the isolates increased, the MBEC/MIC ratio also increased. The CoNS isolated from the catheter samples and blood of patients diagnosed with CRBSI had a 100% similar profile with PFGE except for one unevaluable isolate. The tissue culture plate (TCP) method was found to be most sensitive, accurate and reproducible screening method for detection of biofilm formation by staphylococci and has the advantage of being a quantitative model to study the adherence of staphylococci. The presence of the icaAD and IS256 gene is not always associated with in vitro biofilm formation. For this reason, it is more appropriate to use more than one method together for the evaluation of biofilm formation. It was thought that the use of reliable methods to specifically detect biofilms could be helpful in diseases that are difficult to treat. Considering the high rates of biofilm and antimicrobial resistance of biofilm-forming isolates in biomedical device associated infections, it was determined that it would not be sufficient to evaluate only the MIC results for susceptibility results.
鉴于生物膜介导的感染对患者健康有重大负面影响,且需要一种可靠的表型方法来检测生物膜产生菌,本研究旨在证实从导管相关感染中分离出的凝固酶阴性葡萄球菌(CoNS)的表型和分子生物膜形成情况,并比较所使用的方法。该研究还旨在确定万古霉素的生物膜根除效果,以指导治疗。为检测生物膜形成,共对154株CoNS临床分离株进行筛选,其中30株是导管相关血流感染(CRBSI)的病原体(从15例患者的导管尖端和血培养物中分离),89株从无中心静脉导管(CVC)患者的外周血培养物中分离(其中13株是血流感染病原体,76株是污染物),35株作为导管定植菌,采用组织培养板(TCP)、刚果红琼脂(CRA)法和聚合酶链反应(icaA、icaD和IS256)进行检测。测定了万古霉素最低抑菌浓度(MIC)和最低生物膜根除浓度(MBEC)值。采用脉冲场凝胶电泳(PFGE)法显示从CRBSI患者的导管尖端和外周血中分离出的CoNS之间的克隆关系。在纳入研究的154株CoNS分离株中,38.9%为表皮葡萄球菌(n = 60),34.4%为溶血葡萄球菌(n = 53),20.7%为人葡萄球菌(n = 32),3.8%为头葡萄球菌(n = 6)。在我们的研究中,CRA法显示生物膜形成率为31.